Showing results (181-190 of 201) with videos related to
Sort By:
Pageof 21
The Kaohsiung Journal of Medical Sciences|August 22, 2022
Modifications decrease hepatic steatosis in Taiwanese with metabolic-associated fatty liver diseaseTso-Tsai Liu, He Qiu, Shi-Yu Liu, et al.Journal of Neurogastroenterology and Motility|October 27, 2020
Knowledge, Attitude, and Practice Survey of Gastroparesis in Asia by Asian Neurogastroenterology and Motility AssociationTadayuki Oshima, Kewin T H Siah, Yong Sung Kim, et al.Journal of Neurogastroenterology and Motility|July 7, 2024
Impact of Esophageal Motility on Microbiome Alterations in Symptomatic Gastroesophageal Reflux Disease Patients With Negative Endoscopy: Exploring the Role of Ineffective Esophageal Motility and Contraction ReserveMing-Wun Wong, I-Hsuan Lo, Wei-Kai Wu, et al.Microorganisms|January 26, 2024
Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of <i>Helicobacter pylori</i> InfectionChien-Lin Chen, I-Ting Wu, Deng-Chyang Wu, et al.The American Journal of Gastroenterology|June 25, 2025
Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized TrialPing-I Hsu, Chien-Lin Chen, Chih-An Shih, et al.Gut|September 21, 2023
Updates to the modern diagnosis of GERD: Lyon consensus 2.0C Prakash Gyawali, Rena Yadlapati, Ronnie Fass, et al.Journal of Gastroenterology and Hepatology|November 3, 2019
Planning mass eradication of Helicobacter pylori infection for indigenous Taiwanese peoples to reduce gastric cancerMing-Jong Bair, Shu-Lin Chuang, Wei-Yi Lei, et al.The American Journal of Gastroenterology|March 20, 2023
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized TrialPing-I Hsu, Kuan-Yang Chen, Wei-Chen Tai, et al.World Journal of Gastroenterology|November 3, 2025
Sequential changes of antibiotic resistances of <i>Helicobacter pylori</i> in Taiwan from 2019 to 2024Pei-Jui Wu, Feng-Woei Tsay, Deng-Chyang Wu, et al.Journal of Neurogastroenterology and Motility|May 14, 2013
Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation ToolKok-Ann Gwee, Uday C Ghoshal, Sutep Gonlachanvit, et al.Pageof 21